Glenmark Pharma shares surge 40% on covid-19 drug launch

- Glenmark Pharmaceuticals on Saturday launched antiviral drug favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate covid-19 at a price of about ₹103 per tablet